lifestyle.celebhomes.net
Home
Sample Page
Author:
JenaValve Technology, Inc.
JenaValve Appoints Dave Haan as Vice President of Clinical Affairs
May 12, 2026
JenaValve Announces the Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the United States – the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR)
April 1, 2026
JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System — the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR) in the United States
March 18, 2026
JenaValve Appoints John Molyneux to Vice President of Operations
January 29, 2026